ARA-290 5mg

ARA-290 is a synthetic peptide derived from erythropoietin (EPO), engineered to retain its tissue-protective and anti-inflammatory effects without stimulating red blood cell production. ARA-290 is the side gig that became the main story. Erythropoietin stimulates red blood cell production — its “day job.” But the hormone has another hustle on the go, too. It boosts cell survival, fights inflammation, and boosts reparative processes. The potential is immediately obvious, and studying it has long been on scientists’ wish lists. There’s a catch, though. EPO is massively dangerous. It thickens blood and, thereby, pushes the risk of clots, strokes, and heart attacks through the roof. That took EPO off the table as a research compound, but science never stays stagnant for long. The solution? ARA-290, an 11-amino acid peptide engineered from EPO to switch its protective effects on — minus the life-threatening risks. A quickly growing body of research, including an impressive number of Phase I and II clinical trials, demonstrates the potential. ARA-290 has been researched for neuropathic pain, inflammatory conditions, tissue damage, and more. It gives researchers a way to boost natural repair systems. Safely.